O-001An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes

M Reni, H Riess,E O’Reilly,A Santoro,J Park, T Bekaii-Saab,M Tempero, Y Shan,T Macarulla,E Van Cutsem,M Noel,J Berlin, A Biankin, N Dhani, G Frassineti,D Goldstein, A Romano, Y Le Bruchec, P Philip

Annals of Oncology(2019)

引用 7|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要